HRP20100653T1 - Oralne smjese za apsorpciju fosfornih spojeva - Google Patents
Oralne smjese za apsorpciju fosfornih spojeva Download PDFInfo
- Publication number
- HRP20100653T1 HRP20100653T1 HR20100653T HRP20100653T HRP20100653T1 HR P20100653 T1 HRP20100653 T1 HR P20100653T1 HR 20100653 T HR20100653 T HR 20100653T HR P20100653 T HRP20100653 T HR P20100653T HR P20100653 T1 HRP20100653 T1 HR P20100653T1
- Authority
- HR
- Croatia
- Prior art keywords
- mixture
- binding
- substance
- pharmaceutically acceptable
- calcium
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims 23
- 150000003018 phosphorus compounds Chemical class 0.000 title abstract 2
- 238000010521 absorption reaction Methods 0.000 title 1
- 239000011574 phosphorus Substances 0.000 claims abstract 14
- 229910052698 phosphorus Inorganic materials 0.000 claims abstract 14
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims abstract 6
- 201000005991 hyperphosphatemia Diseases 0.000 claims abstract 3
- 239000000126 substance Substances 0.000 claims 11
- -1 phosphorus compound Chemical class 0.000 claims 10
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims 4
- 229920001661 Chitosan Polymers 0.000 claims 3
- 239000007937 lozenge Substances 0.000 claims 3
- CHRJZRDFSQHIFI-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;styrene Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1C=C CHRJZRDFSQHIFI-UHFFFAOYSA-N 0.000 claims 2
- 201000001320 Atherosclerosis Diseases 0.000 claims 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 2
- 208000000038 Hypoparathyroidism Diseases 0.000 claims 2
- 229910017569 La2(CO3)3 Inorganic materials 0.000 claims 2
- 208000001132 Osteoporosis Diseases 0.000 claims 2
- 229910019142 PO4 Inorganic materials 0.000 claims 2
- 229920002518 Polyallylamine hydrochloride Polymers 0.000 claims 2
- 208000001647 Renal Insufficiency Diseases 0.000 claims 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims 2
- 229940024545 aluminum hydroxide Drugs 0.000 claims 2
- 239000003957 anion exchange resin Substances 0.000 claims 2
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 claims 2
- 235000011092 calcium acetate Nutrition 0.000 claims 2
- 239000001639 calcium acetate Substances 0.000 claims 2
- 229960005147 calcium acetate Drugs 0.000 claims 2
- 235000010410 calcium alginate Nutrition 0.000 claims 2
- 239000000648 calcium alginate Substances 0.000 claims 2
- 229960002681 calcium alginate Drugs 0.000 claims 2
- 229910000019 calcium carbonate Inorganic materials 0.000 claims 2
- 229960003563 calcium carbonate Drugs 0.000 claims 2
- 235000010216 calcium carbonate Nutrition 0.000 claims 2
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 claims 2
- 239000001354 calcium citrate Substances 0.000 claims 2
- 229960004256 calcium citrate Drugs 0.000 claims 2
- 159000000007 calcium salts Chemical class 0.000 claims 2
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims 2
- 208000020832 chronic kidney disease Diseases 0.000 claims 2
- 208000022831 chronic renal failure syndrome Diseases 0.000 claims 2
- 235000009508 confectionery Nutrition 0.000 claims 2
- 238000000502 dialysis Methods 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 150000004676 glycans Chemical class 0.000 claims 2
- 208000017169 kidney disease Diseases 0.000 claims 2
- 150000002603 lanthanum Chemical class 0.000 claims 2
- NZPIUJUFIFZSPW-UHFFFAOYSA-H lanthanum carbonate Chemical compound [La+3].[La+3].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O NZPIUJUFIFZSPW-UHFFFAOYSA-H 0.000 claims 2
- 229960001633 lanthanum carbonate Drugs 0.000 claims 2
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 claims 2
- 235000011285 magnesium acetate Nutrition 0.000 claims 2
- 239000011654 magnesium acetate Substances 0.000 claims 2
- 229940069446 magnesium acetate Drugs 0.000 claims 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims 2
- 239000001095 magnesium carbonate Substances 0.000 claims 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims 2
- 229960001708 magnesium carbonate Drugs 0.000 claims 2
- 235000014380 magnesium carbonate Nutrition 0.000 claims 2
- 159000000003 magnesium salts Chemical class 0.000 claims 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 2
- 239000010452 phosphate Substances 0.000 claims 2
- 229920000083 poly(allylamine) Polymers 0.000 claims 2
- 229920000642 polymer Polymers 0.000 claims 2
- 229920001282 polysaccharide Polymers 0.000 claims 2
- 239000005017 polysaccharide Substances 0.000 claims 2
- 239000003826 tablet Substances 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- 235000013337 tricalcium citrate Nutrition 0.000 claims 2
- 125000000129 anionic group Chemical group 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 230000001055 chewing effect Effects 0.000 claims 1
- 229940112822 chewing gum Drugs 0.000 claims 1
- 235000015218 chewing gum Nutrition 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 239000003456 ion exchange resin Substances 0.000 claims 1
- 229920003303 ion-exchange polymer Polymers 0.000 claims 1
- 239000002324 mouth wash Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000006187 pill Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 239000011347 resin Substances 0.000 claims 1
- 229920005989 resin Polymers 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 230000002459 sustained effect Effects 0.000 claims 1
- 239000006188 syrup Substances 0.000 claims 1
- 235000020357 syrup Nutrition 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 210000003296 saliva Anatomy 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/244—Lanthanides; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Zoology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000015A ITME20040015A1 (it) | 2004-12-07 | 2004-12-07 | Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico. |
| PCT/EP2005/056289 WO2006061336A2 (en) | 2004-12-07 | 2005-11-29 | Oral compositions for absorption of phosphorus compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20100653T1 true HRP20100653T1 (hr) | 2011-01-31 |
Family
ID=36035790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20100653T HRP20100653T1 (hr) | 2004-12-07 | 2010-11-29 | Oralne smjese za apsorpciju fosfornih spojeva |
Country Status (21)
| Country | Link |
|---|---|
| US (4) | US7815898B2 (el) |
| EP (1) | EP1827386B1 (el) |
| JP (1) | JP5049135B2 (el) |
| KR (1) | KR101283820B1 (el) |
| CN (1) | CN101068535A (el) |
| AT (1) | ATE481091T1 (el) |
| BR (1) | BRPI0518517A2 (el) |
| CA (1) | CA2587924C (el) |
| CY (1) | CY1110985T1 (el) |
| DE (1) | DE602005023648D1 (el) |
| DK (1) | DK1827386T3 (el) |
| ES (1) | ES2352957T3 (el) |
| HR (1) | HRP20100653T1 (el) |
| IT (1) | ITME20040015A1 (el) |
| MX (1) | MX2007006704A (el) |
| PL (1) | PL1827386T3 (el) |
| PT (1) | PT1827386E (el) |
| RS (1) | RS51507B (el) |
| RU (1) | RU2392926C2 (el) |
| SI (1) | SI1827386T1 (el) |
| WO (1) | WO2006061336A2 (el) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITME20040015A1 (it) * | 2004-12-07 | 2005-03-07 | Vincenzo Savica | Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico. |
| JP2009507019A (ja) | 2005-09-02 | 2009-02-19 | ジェンザイム・コーポレーション | リン酸塩を除去する方法およびそれに使用される重合体 |
| ITRM20060204A1 (it) * | 2006-04-10 | 2007-10-11 | Vincenzo Savica | Farmaci e alimentei per diete normoproteiche iperproteiche ipopro teiche tutte ipofosforiche e bevande ipofosforiche |
| WO2008005217A2 (en) * | 2006-07-05 | 2008-01-10 | Genzyme Corporation | Iron(ii)-containing treatments for hyperphosphatemia |
| AU2008354325A1 (en) * | 2008-04-08 | 2009-10-15 | Cypress Pharmaceutical, Inc. | Phosphate-binding chitosan and uses thereof |
| US7943597B2 (en) * | 2008-04-08 | 2011-05-17 | Cypress Pharmaceutical, Inc. | Phosphate-binding chitosan and uses thereof |
| US8877907B2 (en) | 2010-06-07 | 2014-11-04 | The Johns Hopkins University | Molecularly imprinted polymers |
| US9314523B2 (en) | 2010-09-21 | 2016-04-19 | Elwha Llc | Ingestible salt grabber |
| EP2441436A1 (de) * | 2010-10-13 | 2012-04-18 | Fresenius Medical Care Deutschland GmbH | Phosphatbinderformulierung zur einfachen Einnahme |
| US9402808B2 (en) | 2011-01-19 | 2016-08-02 | Panacea Biotec Limited | Liquid oral composition of lanthanum salts |
| WO2012143011A1 (en) * | 2011-04-20 | 2012-10-26 | Gumlink A/S | Chewing gum comprising chitosan for use in reduction of the level of free phosphorus compounds in the digestive juice |
| WO2012143008A1 (en) | 2011-04-20 | 2012-10-26 | Gumlink A/S | Reduction of the level of free phosphorus compounds in the digestive juice |
| JP5982473B2 (ja) * | 2011-06-08 | 2016-08-31 | カイ・ファーマシューティカルズ・インコーポレイテッドＫａｉ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． | 血清リンを調節するための治療剤 |
| EP3653061A1 (en) * | 2012-09-04 | 2020-05-20 | The Board of Regents of the University of Texas System | Citrate-rich calcium-magnesium supplement and uses thereof |
| WO2014166545A1 (en) | 2013-04-12 | 2014-10-16 | Cm&D Pharma Ltd | Compositions comprising a mixture of elastomers and chitosan and use thereof for treating disorders of phosphorous mineral metabolism |
| LT3003327T (lt) | 2013-06-05 | 2017-12-27 | Tricida Inc. | Protonus surišantys polimerai, skirti geriamajam vartojimui |
| EP2818176A1 (en) | 2013-06-27 | 2014-12-31 | Virbac | Composition for the treatment of progressive renal diseases |
| CN103536977A (zh) * | 2013-11-04 | 2014-01-29 | 于杰 | 血液灌流器 |
| US9744128B2 (en) | 2014-06-05 | 2017-08-29 | Mastix LLC | Method for manufacturing medicated chewing gum without cooling |
| MX2017007497A (es) | 2014-12-10 | 2017-10-04 | Tricida Inc | Polimeros de union a protones para administracion oral. |
| RU2018142943A (ru) | 2016-05-06 | 2020-06-08 | Трисида, Инк. | Композиции для лечения нарушений кислотно-основного равновесия |
| US10765658B2 (en) | 2016-06-22 | 2020-09-08 | Mastix LLC | Oral compositions delivering therapeutically effective amounts of cannabinoids |
| US11266684B2 (en) | 2017-11-03 | 2022-03-08 | Tricida, Inc. | Compositions for and method of treating acid-base disorders |
| CN111727037A (zh) * | 2017-11-29 | 2020-09-29 | 世展科技股份有限公司 | 肠溶型医药组合物及其用途 |
| US11273123B2 (en) | 2018-07-18 | 2022-03-15 | USpharma Ltd | Chewable pharmaceutical dosage forms |
| CN109528764B (zh) * | 2018-09-30 | 2021-04-06 | 北京市中关村医院 | 一种凝胶基层状无机物磷结合剂及其制备方法和用途 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3818807A (en) * | 1972-12-06 | 1974-06-25 | Eng Concrete Placer Inc | Slurry pump piston seal |
| US4181718A (en) * | 1975-12-29 | 1980-01-01 | Mason Norbert S | Polyanion-stabilized aluminum hydrogels |
| US4163777A (en) * | 1977-04-29 | 1979-08-07 | Lewis/Howe Company | Controlled antacid delivery form and method of treatment therewith |
| US4163177A (en) * | 1977-10-17 | 1979-07-31 | Ward Derrick A | Oscillation generator providing oscillations of varying amplitude |
| US4160820A (en) * | 1977-11-28 | 1979-07-10 | General Mills, Inc. | Plaque inhibiting composition and method |
| US4386106A (en) * | 1981-12-01 | 1983-05-31 | Borden, Inc. | Process for preparing a time delayed release flavorant and an improved flavored chewing gum composition |
| US4515769A (en) * | 1981-12-01 | 1985-05-07 | Borden, Inc. | Encapsulated flavorant material, method for its preparation, and food and other compositions incorporating same |
| US4512968A (en) * | 1982-11-30 | 1985-04-23 | Lion Corporation | Oral compositions |
| EP0187703B1 (en) * | 1985-01-11 | 1992-08-05 | Teijin Limited | Sustained release preparation |
| JPS61161216A (ja) * | 1985-01-11 | 1986-07-21 | Teijin Ltd | キトサン類を用いた徐放性医薬品組成物 |
| JPS62132830A (ja) * | 1985-12-05 | 1987-06-16 | Teijin Ltd | 徐放性医薬品組成物 |
| JPS63310833A (ja) * | 1987-06-10 | 1988-12-19 | Nippon Medical Supply Corp | リン吸着カプセル |
| DE3936319C3 (de) * | 1989-11-01 | 1997-05-07 | Bartz Volker | Phosphatbinder zur oralen Verabreichung |
| US5030459A (en) * | 1989-11-07 | 1991-07-09 | Warner-Lambert Company | High impact mint flavor for high base chewing gum |
| JP2884124B2 (ja) * | 1992-01-31 | 1999-04-19 | 鈴与株式会社 | リン吸着剤 |
| US5496545A (en) * | 1993-08-11 | 1996-03-05 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
| GB9506126D0 (en) * | 1995-03-25 | 1995-05-10 | Johnson Matthey Plc | Pharmaceutical composition and method |
| TW528597B (en) * | 1996-03-05 | 2003-04-21 | Mitsubishi Electric Corp | Medicament for preventive and/or therapeutic treatment of hyperphosphatemia |
| IE980990A1 (en) * | 1998-11-27 | 2000-05-31 | Fuisz Internat Ltd | Composition and Method for Medicated Chewing Gum Delivery System |
| DE19917705C1 (de) | 1999-04-20 | 2000-12-28 | Vitasyn Gmbh | Mittel zur Therapie von Hyperphosphatämie |
| US6645535B2 (en) * | 1999-09-02 | 2003-11-11 | Wm. Wrigley Jr. Company | Method of making coated chewing gum products containing various antacids |
| FI121528B (fi) * | 2000-10-30 | 2010-12-31 | Biohit Oyj | Farmaseuttinen koostumus syöpään sairastumisen riskin vähentämiseen paikallisesti sitomalla asetaldehydi syljessä, mahalaukussa tai paksusuolessa |
| US20030072841A1 (en) * | 2001-03-19 | 2003-04-17 | The Procter & Gamble Campany | Polybutene containing chewing gum and confection |
| ITMI20012320A1 (it) * | 2001-11-06 | 2003-05-06 | Perfetti Van Melle Spa | Composizioni orali solide anti-tartaro e anti-placca batterica, utilicome coadiuvanti nell'igiene odonto-stomatologica |
| WO2003059302A1 (en) * | 2002-01-03 | 2003-07-24 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Edible compositions capable of removing oral biofilm |
| US7244455B2 (en) * | 2002-01-16 | 2007-07-17 | Warner-Lambert Company | Center-filled chewing gum containing a deliverable form of calcium |
| SE0302947D0 (sv) * | 2003-01-24 | 2003-11-07 | Magle Ab | A composition material for transmucosal delivery |
| DE202004021169U1 (de) * | 2003-08-26 | 2007-03-01 | Shire Holdings Ag | Pharmazeutische Formulierung, die Lanthanverbindungen enthält |
| US7459502B2 (en) * | 2003-11-03 | 2008-12-02 | Ilypsa, Inc. | Pharmaceutical compositions comprising crosslinked polyamine polymers |
| US20060177415A1 (en) * | 2004-11-01 | 2006-08-10 | Burke Steven K | Once a day formulation for phosphate binders |
| ITME20040015A1 (it) * | 2004-12-07 | 2005-03-07 | Vincenzo Savica | Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico. |
| US8323683B2 (en) * | 2005-05-18 | 2012-12-04 | Mcneil-Ppc, Inc. | Flavoring of drug-containing chewing gums |
| US20070207206A1 (en) * | 2006-03-02 | 2007-09-06 | Rice Bronwyn C | Chewable pain formula |
-
2004
- 2004-12-07 IT IT000015A patent/ITME20040015A1/it unknown
-
2005
- 2005-11-29 SI SI200531182T patent/SI1827386T1/sl unknown
- 2005-11-29 RS RSP-2010/0513A patent/RS51507B/en unknown
- 2005-11-29 WO PCT/EP2005/056289 patent/WO2006061336A2/en active Application Filing
- 2005-11-29 ES ES05810997T patent/ES2352957T3/es active Active
- 2005-11-29 US US11/792,047 patent/US7815898B2/en not_active Expired - Fee Related
- 2005-11-29 KR KR1020077012746A patent/KR101283820B1/ko not_active IP Right Cessation
- 2005-11-29 CA CA2587924A patent/CA2587924C/en not_active Expired - Fee Related
- 2005-11-29 PL PL05810997T patent/PL1827386T3/pl unknown
- 2005-11-29 JP JP2007544881A patent/JP5049135B2/ja not_active Expired - Fee Related
- 2005-11-29 MX MX2007006704A patent/MX2007006704A/es active IP Right Grant
- 2005-11-29 AT AT05810997T patent/ATE481091T1/de active
- 2005-11-29 PT PT05810997T patent/PT1827386E/pt unknown
- 2005-11-29 DE DE602005023648T patent/DE602005023648D1/de active Active
- 2005-11-29 DK DK05810997.6T patent/DK1827386T3/da active
- 2005-11-29 EP EP05810997A patent/EP1827386B1/en active Active
- 2005-11-29 RU RU2007125702/15A patent/RU2392926C2/ru not_active IP Right Cessation
- 2005-11-29 BR BRPI0518517-3A patent/BRPI0518517A2/pt not_active IP Right Cessation
- 2005-11-29 CN CNA2005800414580A patent/CN101068535A/zh active Pending
-
2010
- 2010-08-23 US US12/861,539 patent/US20100316578A1/en not_active Abandoned
- 2010-09-16 US US12/883,498 patent/US8518379B2/en not_active Expired - Fee Related
- 2010-11-29 HR HR20100653T patent/HRP20100653T1/hr unknown
- 2010-12-10 CY CY20101101144T patent/CY1110985T1/el unknown
-
2014
- 2014-08-18 US US14/462,038 patent/US20140356297A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20100316578A1 (en) | 2010-12-16 |
| DE602005023648D1 (de) | 2010-10-28 |
| MX2007006704A (es) | 2008-01-16 |
| WO2006061336A2 (en) | 2006-06-15 |
| CA2587924A1 (en) | 2006-06-15 |
| CA2587924C (en) | 2013-08-20 |
| KR101283820B1 (ko) | 2013-07-15 |
| CN101068535A (zh) | 2007-11-07 |
| JP5049135B2 (ja) | 2012-10-17 |
| US7815898B2 (en) | 2010-10-19 |
| EP1827386B1 (en) | 2010-09-15 |
| US20110002858A1 (en) | 2011-01-06 |
| JP2008523022A (ja) | 2008-07-03 |
| KR20070090904A (ko) | 2007-09-06 |
| RU2392926C2 (ru) | 2010-06-27 |
| DK1827386T3 (da) | 2011-07-11 |
| US20080125394A1 (en) | 2008-05-29 |
| PL1827386T3 (pl) | 2011-05-31 |
| US8518379B2 (en) | 2013-08-27 |
| EP1827386A2 (en) | 2007-09-05 |
| WO2006061336A3 (en) | 2006-09-14 |
| BRPI0518517A2 (pt) | 2008-11-25 |
| ITME20040015A1 (it) | 2005-03-07 |
| RS51507B (en) | 2011-06-30 |
| RU2007125702A (ru) | 2009-01-20 |
| ES2352957T3 (es) | 2011-02-24 |
| PT1827386E (pt) | 2010-12-03 |
| ATE481091T1 (de) | 2010-10-15 |
| CY1110985T1 (el) | 2015-06-11 |
| SI1827386T1 (sl) | 2011-01-31 |
| US20140356297A1 (en) | 2014-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20100653T1 (hr) | Oralne smjese za apsorpciju fosfornih spojeva | |
| ES2787220T3 (es) | Cápsulas blandas llenas de líquido | |
| TWI446906B (zh) | 以γ－羥基丁酸為基礎的新穎組成物 | |
| AU2011316103B2 (en) | Phosphate binder formulation for simple ingestion | |
| JP2002539245A5 (el) | ||
| CZ156598A3 (cs) | Použití flurbiprofenu k přípravě léčiva k léčení bolesti v krku | |
| KR20090094076A (ko) | 아세트아미노펜／이부프로펜 병용물 | |
| AU607153B2 (en) | Oral sustained release composition of sodium monofluorophasphate and a calcium containing composition | |
| US20220008331A1 (en) | Pharmaceutical compositions comprising flurbiprofen | |
| US20170157001A1 (en) | Compositions Comprising Strontium and Uses Thereof in the Treatment or Prevention of Gingivitis, Periodontitis, Periodontitis as a Manifestation of Systemic Diseases, and Necrotizing Periodontal Diseases | |
| SK284728B6 (sk) | Farmaceutický prostriedok obsahujúci ibuprofen a domperidone na ošetrovanie migrény | |
| ES2952013T3 (es) | Combinación de ibuprofeno y tramadol para aliviar el dolor | |
| AU4307396A (en) | Kit for osteoporosis treatment cycle | |
| EP3880201A1 (en) | Use of gaboxadol for the treatment of non-24 hour sleep-wake disorder | |
| CN102138893A (zh) | 制备赖氨洛芬氯化钠注射液的工艺方法及其用途 | |
| JP2017160192A (ja) | 経口製剤 | |
| TR201511854A1 (tr) | Oral terapöti̇k formülasyonlar |